Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CAH 
Cardinal Health Inc (CAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/07/2025: CAH (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
17 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $179.93
1 Year Target Price $179.93
| 9 | Strong Buy |
| 2 | Buy |
| 5 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 33.38% | Avg. Invested days 52 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/07/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 37.77B USD | Price to earnings Ratio 24.51 | 1Y Target Price 179.93 |
Price to earnings Ratio 24.51 | 1Y Target Price 179.93 | ||
Volume (30-day avg) 17 | Beta 0.68 | 52 Weeks Range 96.55 - 168.44 | Updated Date 08/6/2025 |
52 Weeks Range 96.55 - 168.44 | Updated Date 08/6/2025 | ||
Dividends yield (FY) 1.28% | Basic EPS (TTM) 6.39 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-12 | When - | Estimate 2.03 | Actual - |
Profitability
Profit Margin 0.7% | Operating Margin (TTM) 1.33% |
Management Effectiveness
Return on Assets (TTM) 3.13% | Return on Equity (TTM) - |
Valuation
Trailing PE 24.51 | Forward PE 17.09 | Enterprise Value 42121249271 | Price to Sales(TTM) 0.17 |
Enterprise Value 42121249271 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 0.19 | Enterprise Value to EBITDA 13.92 | Shares Outstanding 238676992 | Shares Floating 238135208 |
Shares Outstanding 238676992 | Shares Floating 238135208 | ||
Percent Insiders 0.29 | Percent Institutions 89 |
Upturn AI SWOT
Cardinal Health Inc
Company Overview
History and Background
Cardinal Health, Inc. was founded in 1971 as Cardinal Foods, a food wholesaler. It transformed into a pharmaceutical distributor through acquisitions in the 1980s and 1990s, becoming a major player in healthcare supply chain management.
Core Business Areas
- Pharmaceutical Distribution: Distributes branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products to hospitals, pharmacies, and other healthcare providers.
- Medical Segment: Manufactures and distributes medical, surgical, and laboratory products, and provides supply chain and logistics services to hospitals and other healthcare providers.
Leadership and Structure
The CEO is Jason Hollar. Cardinal Health operates with a corporate structure including various divisions overseeing pharmaceutical and medical segments. The board of directors provides oversight and strategic guidance.
Top Products and Market Share
Key Offerings
- Pharmaceutical Distribution Services: Cardinal Health's core offering is pharmaceutical distribution, which accounts for a significant portion of its revenue. Competitors include McKesson and AmerisourceBergen. Market share data fluctuates, but Cardinal Health consistently holds a substantial portion of the US pharmaceutical distribution market. Exact revenue figures for this specific service are not publicly broken out.
- Medical Products and Services: This includes a wide range of medical, surgical, and laboratory products, as well as supply chain solutions. Competitors vary by specific product category and includes 3M, Medline Industries and Owens & Minor. This segment generates significant revenue, but specific revenue breakdowns and market share data are proprietary.
Market Dynamics
Industry Overview
The healthcare supply chain industry is characterized by consolidation, regulatory scrutiny, and increasing focus on cost efficiency. It is heavily influenced by healthcare reform, drug pricing pressures, and technological advancements.
Positioning
Cardinal Health is one of the 'Big Three' pharmaceutical distributors in the US, alongside McKesson and AmerisourceBergen. Its competitive advantages include its scale, established relationships with healthcare providers, and comprehensive supply chain solutions.
Total Addressable Market (TAM)
The total addressable market is estimated to be hundreds of billions of dollars annually. Cardinal Health is well positioned to capture a significant portion of this TAM due to its established market presence and comprehensive service offerings.
Upturn SWOT Analysis
Strengths
- Large scale and market share
- Established relationships with healthcare providers
- Comprehensive supply chain solutions
- Strong distribution network
- Diversified product portfolio
Weaknesses
- Exposure to generic drug pricing pressures
- Dependence on a few large customers
- Litigation and regulatory risks
- Debt Load
- Pricing pressures with the shift from brand to generic drugs.
Opportunities
- Expanding healthcare services
- Growth in specialty pharmaceuticals
- Increasing demand for supply chain optimization
- International expansion
- Technological innovations in healthcare
Threats
- Intense competition
- Regulatory changes and healthcare reform
- Drug shortages
- Economic downturns impacting healthcare spending
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- MCK
- ABC
- CAH
Competitive Landscape
Cardinal Health competes with McKesson and AmerisourceBergen for market share. Cardinal Health is making new efforts in generic pharmaceutical development in order to improve margins. However, McKesson has a higher market share.
Major Acquisitions
NaviHealth
- Year: 2022
- Acquisition Price (USD millions): 600
- Strategic Rationale: This acquisition expanded Cardinal Health's presence in the post-acute care market, allowing them to offer more comprehensive services to healthcare providers.
Growth Trajectory and Initiatives
Historical Growth: Cardinal Health's historical growth has been driven by acquisitions and organic growth in its pharmaceutical and medical segments.
Future Projections: Analyst estimates vary, but projections generally indicate moderate revenue growth and EPS growth, driven by aging demographics and increasing healthcare spending.
Recent Initiatives: Recent initiatives include investments in data analytics, supply chain optimization, and expansion of specialty pharmaceutical services.
Summary
Cardinal Health is a major player in the pharmaceutical distribution and medical products industries. It is working on improvements to generics and specialty pharma. However, generic drug pricing and regulatory pressures may impact future growth. The company benefits from economies of scale and established market position. The need for continued innovation and cost management is crucial.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Investor Relations
- Market Research Reports
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data are estimates and may vary. Financial data are subject to change. All investments involve risk, and you should consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cardinal Health Inc
Exchange NYSE | Headquaters Dublin, OH, United States | ||
IPO Launch date 1987-12-31 | CEO & Director Mr. Jason M. Hollar | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 47922 | Website https://www.cardinalhealth.com |
Full time employees 47922 | Website https://www.cardinalhealth.com | ||
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.